4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0000950170-24-008020
President and CEO sold 91,052 shares at $20.23 ($1,841,982)
- President and CEO acquired 91,052 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
WILSON TROY EDWARD · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-24 | Exercise or conversion : show line 1 in the form | +6,945 | $4.80 | $33,336 | 7,504 | D |
| 2024-01-24 | Sale : show line 2 in the form | −6,945 | $20.23 | $140,497 | 559 | D |
| 2024-01-24 | Exercise or conversion : show line 3 in the form | +84,107 | $6.15 | $517,258 | 84,666 | D |
| 2024-01-24 | Sale : show line 4 in the form | −84,107 | $20.23 | $1,701,485 | 559 | D |
| Open-market sales · 91,052 sh · avg $20.23 · $1,841,982 | ||||||
Loading xslF345X05/ownership.xml…